Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics in clinical dermatology.

The British journal of dermatology - 1 Jan 2002

Ameen M, Smith C H, Barker J N W N

Abstract excerpt

Systemic therapies are increasingly used in the management of common skin diseases, and drug toxicity and relative lack of efficacy remain significant problems. In addition, we are unable to predict life-threatening adverse reactions such as toxic epidermal necrolysis. Pharmacogenetics, the study of how genetic differences influence the variability of individual patient responses to drugs, aims to distinguish...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug-Related Side Effects and Adverse Reactions
Share to Drug Resistance
Share to Ethics, Medical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Oligonucleotide Array Sequence Analysis

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Research Design

Source

Identifiers

PMID: 11841360
DOI: 10.1046/j.1365-2133.2002.04466.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics in clinical dermatology.PMID 11841360Read ↗

Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy.Semantic proximity Read ↗

[Pharmacogenomics in dermatology].Semantic proximity Read ↗

Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction.Semantic proximity Read ↗

Pharmacogenetics of psoriasis.Semantic proximity Read ↗

The Latest Advances in Pharmacogenetics and Pharmacogenomics in the Treatment of PsoriasisSemantic proximity Read ↗

Pharmacogenetic markers of severe cutaneous adverse drug reactions.Semantic proximity Read ↗

Pharmacogenomics of adverse drug reactions: implementing personalized medicine.Semantic proximity Read ↗

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art.Semantic proximity Read ↗

Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via PharmacogenomicsSemantic proximity Read ↗

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationSemantic proximity Read ↗

Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.Semantic proximity Read ↗

Assessing genotypes to predict therapeutic outcome in psoriasis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.